Back

The significance of NT-proBNP plasma concentration at baseline for predicting outcomes after CRT-D implantation in heart failure patients

27 May 2018 (08:30 - 18:00)
Organised by:
Congress Presentation Part of: Poster Session 2 - Cardiac Resynchronization Therapy Cardiac Resynchronisation Therapy (CRT) HFA Premium Access Heart Failure 2018

About the speaker

Photo
Doctor Michal Kerekanic

East Slovak Institute of Cardiovascular Diseases, Kosice (Slovakia)

3 More presentations in this session

Presentation thumbnail
Assistant Professor G. Alonso Salinas (Pamplona, ES)
Abstract Slides
Presentation thumbnail
Presentation thumbnail
Doctor M. Casale (Urbino, IT)

Access the full session

Session thumbnail
Poster Session 2 - Cardiac Resynchronization Therapy

The Event

Event poster

Heart Failure 2018

27 May 2018 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Predictors of cardiac resynchronized therapy response and maximum allowable medical treatment period in dilated cardiomyopathy with left bundle branch block
13 May 2024
thumbnail
Congress Presentation
Serial measurements of NT-ProBNP to quantify perioperative hemodynamic cardiac stress and predict outcomes after major non-cardiac surgery
1 September 2025
thumbnail
Congress Presentation
Effects of inspiratory muscle training on NT-proBNP level, functional exercises capacity and quality of life in patients with cardiac resynchronization therapy: a pilot study
26 April 2024
thumbnail
Congress Session
From genetic signatures to clinical implications
18 May 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources